C07D 285/12
1,3,4-thiadiazoles
Official title: 1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
C07D285/12 (1,3,4-thiadiazoles) appears on 1,209 US grants and 703 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,209
- Published applications
- 703
- Assignees
- 477
- Inventors
- 3,044
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 38 | 0 |
| 1977 | 46 | 0 |
| 1978 | 42 | 0 |
| 1979 | 33 | 0 |
| 1980 | 32 | 0 |
| 1981 | 48 | 0 |
| 1982 | 19 | 0 |
| 1983 | 22 | 0 |
| 1984 | 19 | 0 |
| 1985 | 18 | 0 |
| 1986 | 18 | 0 |
| 1987 | 24 | 0 |
| 1988 | 17 | 0 |
| 1989 | 17 | 0 |
| 1990 | 27 | 0 |
| 1991 | 25 | 0 |
| 1992 | 35 | 0 |
| 1993 | 35 | 0 |
| 1994 | 28 | 0 |
| 1995 | 25 | 0 |
| 1996 | 22 | 0 |
| 1997 | 26 | 0 |
| 1998 | 25 | 0 |
| 1999 | 25 | 0 |
| 2000 | 16 | 0 |
| 2001 | 23 | 4 |
| 2002 | 16 | 17 |
| 2003 | 17 | 18 |
| 2004 | 12 | 36 |
| 2005 | 11 | 30 |
| 2006 | 15 | 29 |
| 2007 | 20 | 35 |
| 2008 | 13 | 38 |
| 2009 | 23 | 37 |
| 2010 | 24 | 54 |
| 2011 | 30 | 35 |
| 2012 | 41 | 35 |
| 2013 | 33 | 37 |
| 2014 | 38 | 46 |
| 2015 | 32 | 36 |
| 2016 | 34 | 28 |
| 2017 | 23 | 34 |
| 2018 | 25 | 32 |
| 2019 | 30 | 20 |
| 2020 | 18 | 19 |
| 2021 | 12 | 21 |
| 2022 | 11 | 18 |
| 2023 | 4 | 11 |
| 2024 | 9 | 23 |
| 2025 | 11 | 6 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- 2,5-dimercapto-1,3,4-thiadiazole (DMTD) zinc salt derivatives28 Apr 2026US 12,614,716 B2Ohio State Innovation Foundation
- Substituted thiolate salt melt additives17 Feb 2026US 12,552,914 B23M Innovative Properties Company
- Heteroaryl-thio-substituted pyrones9 Dec 2025US 12,492,341 B2Iowa State University Research Foundation, Inc.
- Sulphonyl urea derivatives as NLRP3 inflammasome modulators4 Nov 2025US 12,459,925 B2NodThera Limited
- Compositions and methods for making and using small molecules in the treatment of cancer2 Sep 2025US 12,404,242 B2Reglagene, Inc.
- Adar1 inhibitors and methods of using the same16 Jul 2026US 2026/0200890 A1Aten Porus Lifesciences Pvt. Ltd.
- Sirtuin modulating compounds, including sirtuin activating compounds, and applications thereof23 Apr 2026US 2026/0109713 A1
- Inhibitor of PFKFB2 Kinase Activity and Cellular Glycolysis16 Apr 2026US 2026/0102379 A1
- Novel inhibitors1 Jan 2026US 2026/0001873 A1Vivoryon Therapeutics N.V.
- Carbonic anhydrase inhibitors and antibiotics against multidrug resistant bacteria23 Oct 2025US 2025/0328351 A1
Most cited
By later US patents
- Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase183US 5,409,944 AMerck Frosst Canada, Inc. · 1995
- Amide derivatives176US 4,636,505 AImperial Chemical Industries PLC · 1987
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008
- Aryl carbonyl derivatives as therapeutic agents123US 7,541,373 B2Novo Nordisk A/S · 2009
- Modulators of ATP-binding cassette transporters106US 7,977,322 B2Vertex Pharmaceuticals Incorporated · 2011